Biliary mucin secreted by cultured human gallbladder epithelial cells carries the epitope of CA 19-9VON RITTER, C; EDER, M. I; STIEBER, P et al.Anticancer research. 1997, Vol 17, Num 4B, pp 2931-2934, issn 0250-7005Conference Paper

Cobas® core CA 19-9 II EIA: New CA 19-9 enzyme immunoassay with high correlation to radioimmunoassaysBIRK, B; HENNE, V; HIPP, B et al.Anticancer research. 1997, Vol 17, Num 4B, pp 2911-2914, issn 0250-7005Conference Paper

Utility of the antibodies CA 19-9, HBME-1, and thrombomodulin in the diagnosis of malignant mesothelioma and adenocarcinoma in cytologyFETSCH, P. A; ABATI, A; HIJAZI, Y. M et al.Cancer. 1998, Vol 84, Num 2, pp 101-108, issn 0008-543XArticle

Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinomaGRANKVIST, K; LJUNGBERG, B; RASMUSON, T et al.International journal of cancer. 1997, Vol 74, Num 2, pp 233-236, issn 0020-7136Article

Diagnostic, prognostic and monitoring value of CA 72.4 in gastric cancer. A prospective study including CA 19.9 and CEACAZIN, J. L; GAMBIER, L; GOSSELIN, P et al.Immuno analyse & biologie spécialisée. 1998, Vol 13, Num 3, pp 141-150, issn 0923-2532Article

Specific activation of resting T cells against CA19-9+ tumor cells by an anti-CD3/CA19-9 bispecific antibody in combination with a costimulatory anti-CD28 antibodyHOMBACH, A; TILLMANN, T; JENSEN, M et al.Journal of immunotherapy with emphasis on tumor immunology. 1997, Vol 20, Num 5, pp 325-333, issn 1067-5582Conference Paper

Relevance of SCC-Ag, cea, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancerKRIMMEL, M; HOFFMANN, J; KRIMMEL, C et al.Journal of cranio-maxillo-facial surgery. 1998, Vol 26, Num 4, pp 243-248, issn 1010-5182Article

Evaluation de la trousse ACS : 180 GI® Chiron Diagnostics (dosage du CA 19-9) = Evaluation of a CA 19-9 assay on the ACS : 180® analyser Chiron Diagnostics (ACS : 180® GI)BEAUDONNET, A; MAILLIAVIN, A; GELINEAU, M. C et al.Immuno analyse & biologie spécialisée. 1998, Vol 13, Num 3, pp 174-179, issn 0923-2532Article

CA 19-9 as a marker for gastrointestinal cancers : a reviewDUFFY, M. J.Annals of clinical biochemistry. 1998, Vol 35, pp 364-370, issn 0004-5632, 3Article

Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinomaREITER, W; STEBER, P; REUTER, C et al.Anticancer research. 1997, Vol 17, Num 4B, pp 2903-2906, issn 0250-7005Conference Paper

CEA, TPA, CA 19-9, SCC and CYFRA at diagnosis and in the follow-up of anal canal tumorsINDINNIMEO, M; REALE, M. G; CICCHINI, C et al.International surgery. 1997, Vol 82, Num 3, pp 275-279, issn 0020-8868Article

Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinomaREITER, W; STIEBER, P; REUTER, C et al.Anticancer research. 1997, Vol 17, Num 4B, pp 2935-2938, issn 0250-7005Conference Paper

Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevanceGEBAUER, G; MÜLLER-RUCHHOLTZ, W.Anticancer research. 1997, Vol 17, Num 4B, pp 2939-2942, issn 0250-7005Conference Paper

Serum tumor markers after renal transplantationOBERBAUER, R; BANYAI, S; SCHMIDT, A et al.Transplantation. 1996, Vol 62, Num 10, pp 1506-1509, issn 0041-1337Article

Élévation du CA 19.9 sérique et bronchectasies Méfaits du dosage inapproprié d'un marqueur tumoral à visée de dépistage = Increased Serum CA 19.9 in bronchiectasisYANGO, J; PIETERS, T; COCHE, E et al.Revue des maladies respiratoires. 2008, Vol 25, Num 1, pp 78-81, issn 0761-8425, 4 p.Article

Giant splenic cyst with high serum concentration of CA 19-9 : Failure of treatment with percutaneous transcatheter drainage and injection of tetracyclineYOSHIKANE, H; SUZUKI, T; YOSHIOKA, N et al.Scandinavian journal of gastroenterology. 1996, Vol 31, Num 5, pp 524-526, issn 0036-5521Article

Cancer urothélial métastatique associé à une élévation marquée du CA 19.9 sérique = Metastatic transitional cell carcinoma with high CA 19.9 serum levelsCAMAIN, Jean-Yves; HAMMEL, Pascal; CAZALS-HATEM, Dominique et al.Gastroentérologie clinique et biologique. 2007, Vol 31, Num 1, pp 102-105, issn 0399-8320, 4 p.Article

Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinomaTAKESHIMA, N; SHIMIZU, Y; UMEZAWA, S et al.Gynecologic oncology (Print). 1994, Vol 54, Num 3, pp 321-326, issn 0090-8258Article

CA-50 and CA-19.9 immunoreactivities in human seminal plasmaGONZALEZ BUITRAGO, J. M; MOYANO, J. C; MARTIN DOMINGUEZ, T et al.Journal of tumor marker oncology. 1991, Vol 6, Num 2, pp 91-95, issn 0886-3849Article

Levels of CA-19.9, CA-125, and CA-195 in seminal plasma and in vitro fertilization ratesMATORRAS, R; GENOLLA, J; DIEZ, J et al.Fertility and sterility. 1995, Vol 63, Num 3, pp 604-607, issn 0015-0282Article

Evaluation of six tumor markers in patients with carcinoma of unknown primaryPAVLIDIS, N; KALEF-EZRA, J; FOUNTZILAS, G et al.Medical and pediatric oncology. 1994, Vol 22, Num 3, pp 162-167, issn 0098-1532Article

L'antigène carbohydrate CA 50. Intérêt du dosage du CA 50 comparé au CA 19.9 = The CA 50 carbohydrate antigen. Comparison of dosage between CA 50 and CA 19.9MELEY, R; SOTTA, C; MARCAIS, C et al.Lyon pharmaceutique. 1993, Vol 44, Num 6, pp 379-385, issn 0024-7804Article

The role of the leukocyte adherence inhibition (LAI), CA 19-9, and tissue polypeptide antigen (TPA) tests in the diagnosis of pancreatic cancerMEDURI, F; DONI, M. G; MERENDA, R et al.Cancer. 1989, Vol 64, Num 5, pp 1103-1106, issn 0008-543XArticle

Tumor markers in the diagnosis of malignant serous effusionsCASCINU, S; DEL FERRO, E; BARBANTI, I et al.American journal of clinical oncology. 1997, Vol 20, Num 3, pp 247-250, issn 0277-3732Article

Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancerSAFI, F; KUHNS, V; BEGER, H. G et al.The International journal of biological markers. 1995, Vol 10, Num 2, pp 100-106, issn 0393-6155Article